CRM setup for medical device companies

Quick answer

A medical device CRM has to hold a long, multi-stakeholder deal together for a year or more. Model the hospital or health system as the account, the clinical, biomed, procurement and finance people as contacts with their committee roles, and add fields for evidence status, biomed sign-off, group purchasing contracts and the next value-analysis committee date. Build stages that match the hospital's buying gates, set hygiene rules from day one, and the CRM becomes the single place a 12 to 24 month device deal stays legible. Get the data model right first; everything else plugs into it.

Why device CRM setup is its own problem

A CRM set up for a fast SaaS motion falls apart on a medical device deal. It assumes one or two contacts, a short cycle, and a budget already approved. A device deal has 8 to 15 stakeholders, runs 12 to 24 months, and only gets a budget after a committee approves it.

If you sell devices out of a spreadsheet and your inbox, the cost shows up a year in: you cannot remember what evidence the committee asked for, who signed off on biomed, or when the group purchasing contract renews. The deal does not die loudly. It just loses its thread. The CRM exists to stop that, which means it has to be built around how hospitals actually buy. The general setup discipline is in how to set up a CRM; this is the device-specific version.

How should you model accounts and the committee?

Model the buying structure, not a flat list of leads.

• Account = the hospital or health system. For multi-site systems, decide early whether a parent system and its hospitals are one account with child records or separate accounts, because procurement and GPO contracts often sit at the system level while clinical champions sit at the site.
• Contacts = the committee. Every stakeholder is a contact with a role field, drawn from the roles the medical devices page sets out: clinician or department head (champion), biomed or clinical engineering (safety and integration gatekeeper), value-analysis committee member, procurement and GPO, and the executive or finance sponsor.
• The VAC as a trackable thing. The value-analysis committee is not a single contact; it is a gate with a schedule. Track when it meets, what it asked for, and where your submission stands.

Gartner has found the typical B2B buying group involves six to ten decision makers. Medical devices run at the top of that range and past it, so a CRM built around lone contacts will always understate where a deal really is. Build around accounts and the committee inside them. For finding and reaching those people in the first place, see how to find and reach medical device buyers.

What pipeline stages belong in the CRM?

Stages should mirror the hospital's buying gates so that stage equals real progress. A workable default:

Each stage needs one clear exit criterion. Generic templates with "demo" and "proposal" do not survive contact with a committee. The deeper build of this pipeline is in how to build a sales pipeline for a medical device company, and the general stage principles in best CRM for startups cover how to pick a system you can configure this way without a consultant.

Which fields actually matter?

Capture what you will report on and nothing you will not maintain. Every required field you never use is a tax on every rep forever. For device deals the fields that earn their place are:

• Stakeholder role on the committee, per contact.
• Evidence status: what the champion and the VAC have accepted, and what is still outstanding.
• Biomed sign-off status.
• GPO or group purchasing contract and its renewal or expiry date.
• Next VAC meeting date and the submission status.
• Expected decision window, so a multi-quarter forecast is grounded.

These few fields are what let you forecast a long cycle and tell a stalled deal from one that is simply waiting on the next committee meeting.

What hygiene rules keep a year-long deal clean?

Dirty data is far cheaper to prevent than to fix, and a device deal gives dirt a year to accumulate. Set the rules before you load a single account:

1. Deduplication and naming. Hospitals and health systems have messy, overlapping names and many sites. Agree a naming convention and a dedup rule up front, or you will end up with the same system entered three ways.
2. One owner per account. With 8 to 15 stakeholders, it has to be clear who is responsible for keeping the account current.
3. Activity logged against the account, not a lone contact. The committee is the opportunity, so touches, evidence requests and meeting notes belong at the account level where the whole team can see them.
4. Required fields only where you will maintain them. Evidence status and next VAC date are worth enforcing. Vanity fields are not.

Where Enablemnt fits

Everything above is setup work: a data model that holds a hospital and its committee, stages that match the buying gates, the right handful of fields, and hygiene rules that survive a year-long deal. It is a few focused days done right, or weeks of messy iteration done wrong, and a founder closing early deals rarely has either to spare.

Enablemnt is your embedded RevOps team. We build the CRM this article describes in a fixed 14-day sprint: accounts and committees modeled per hospital, stages and fields built for long device cycles, and hygiene rules set from day one, with live outbound on top. You own all of it at the end, documented, and can run it yourself or keep us on to operate it.

If you are standing up a device CRM for the first time and want it done right the first time, tell us about your company and we will map your GTM blueprint on a short call.

Filed under By industry. Written by Enablemnt AI.